Eight
minutes.
Every signal.

The clearance covers autonomous AI triage for pneumothorax and pleural effusion in emergency settings. Unlike previous approvals, this one includes a provision for asynchronous reads — meaning the AI can flag studies even when no radiologist is logged into the PACS. For innovation officers, the procurement angle is straightforward: the ROI case writes itself when you quantify overnight turnaround time. The nuance is in liability allocation, and that's where most vendor negotiations are currently stalling.

Read the term sheet language carefully and you'll notice "ambient documentation" is a trojan horse. The real play is owning the structured data layer that sits between physician speech and the EHR. Once you control that translation layer — and the clinical ontologies that power it — you're positioned for a very different kind of enterprise contract than a transcription SaaS would command.

The rule requires payers to respond to prior authorization requests within 72 hours for urgent care and 7 days for standard requests, delivered via FHIR API. The penalty structure is what's changed: non-compliant payers face public reporting on CMS's website, which maps directly to employer plan selection cycles. Three large regional Blues plans told us off the record they're planning to request extensions.

The distinction that matters: are you taking downside risk, or are you selling software to organizations that take downside risk? The former is a fundamentally different business model — different capital structure, different sales cycle, different exit path. At least six companies in the last month's funding announcements described themselves as "value-based" while operating squarely in the second category. The VCs writing those checks know the difference. The founders sometimes don't.

The trial found no statistically significant improvement in HbA1c for non-diabetic participants using CGM versus standard care. However, the CGM group showed meaningful changes in dietary behavior as measured by food diary compliance. The wellness CGM industry is now citing the behavioral change data while quietly omitting the primary endpoint miss. For payers evaluating coverage decisions, the distinction matters enormously — you're not buying a metabolic intervention, you're buying an engagement tool.

The network effects are now quantifiable: health systems with Epic report 40% faster implementation timelines for validated App Orchard vendors versus non-validated competitors. That's an enormous procurement advantage. The implication for founders: if you're selling into Epic shops, the certification conversation needs to happen at Series A, not after your first enterprise contract.

Health systems are buying RPM vendors not for the technology but for the enrolled patient populations. Each acquisition came with 8,000–15,000 active enrolled patients, which translates directly into chronic care management billing codes. The acquirers in all three cases were regional systems competing with national insurers moving into provider-sponsored plans. The RPM patient panel is the asset; the software is almost incidental.

The ONC is deliberately building case law against EHR vendors before turning enforcement attention to health systems. The strategy makes political sense: vendors have less lobbying leverage than hospital associations. But the practical effect is that health systems have a narrowing window to audit their own information blocking exposure before enforcement attention shifts. Legal teams at systems with Epic, Cerner, and Oracle Health contracts should be reviewing their data sharing agreements now.

The healthtech information landscape has a supply problem — there's too much of it, and almost none of it is curated by people who have actually sat in a hospital boardroom, run a Series A diligence process, or navigated a 510(k) submission. Dispatch exists because the people who need to make consequential decisions in this industry deserve better than aggregated press releases with light commentary. We'll tell you what we think, why we think it, and when we're wrong.